NeueHealth, Inc.
NEUE
$6.84
-$0.035-0.51%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 26.23% | 98.82% | 90.94% | 48.04% | 90.91% |
Total Depreciation and Amortization | -21.99% | -63.58% | -15.01% | -14.82% | -16.81% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 4,120.30% | -28.85% | -90.21% | -3.98% | -99.35% |
Change in Net Operating Assets | 35.97% | 113.08% | 98.93% | 80.67% | 92.26% |
Cash from Operations | 56.79% | 92.64% | 98.70% | 73.92% | 92.08% |
Capital Expenditure | -1,503.13% | -191.88% | -186.64% | -53.11% | 96.56% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -68.83% | -- | -- | 148.29% | 14,216.06% |
Other Investing Activities | 31.97% | 93.95% | -99.94% | 98.24% | -99.66% |
Cash from Investing | -68.16% | 90.95% | -100.01% | 98.28% | -71.11% |
Total Debt Issued | -- | 385.80% | -120.56% | -- | -- |
Total Debt Repaid | 99.63% | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 9.66% | -1,153.15% | 24.82% | 9.56% | -4.38% |
Cash from Financing | 99.02% | -260.41% | -128.98% | 1,675.49% | -15,172.73% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 131.33% | 88.22% | 94.50% | 101.87% | -279.89% |